- Masimo, the company that sued Apple over patent infringement, has unveiled its own blood oxygen monitoring smartwatch called the Masimo Freedom.
- The Masimo Freedom is a health-focused device that can track blood oxygen levels, hydration index, respiration rate, pulse rate variability, pulse rate, steps, and detect falls.
- The smartwatch is currently in prototype stage and will be available for sale later this year at a price of $999.
Archive link: https://archive.ph/aOUXX
Nobody is buying this and I don’t think they are trying very hard to sell it either. Notice that this pricing is only in the U.S. This seems like a ploy to bolster their case for damages and/or royalties in a settlement. Or maybe just part of their patent defense strategy. This company is primarily in medical tech. Even if they aren’t so interested in the consumer market, they have to protect their patent or someone in a market they do care about will get away with it too. I would assume it strengthens their case if they can demonstrate material damages in a market they participate in. So quickly unveil a prototype, price it so there’s little to no demand, don’t bother manufacturing a product nobody wants, win the case, cancel the product.
